No abstract available.
Balloon Valvuloplasty* ; Constriction, Pathologic*

No abstract available.
Balloon Valvuloplasty* ; Pulmonary Valve Stenosis* ; Pulmonary Valve*

No abstract available.
Balloon Valvuloplasty* ; Tricuspid Valve Stenosis* ; Tricuspid Valve*

No abstract available.
Balloon Valvuloplasty* ; Child* ; Constriction, Pathologic* ; Humans

BACKGROUND: Alterations in ventricular loading conditions lead to changes in action potential duration via mechanoelectrical feedback. A decrease in load immediately leads to prolongation of repolarization. QT interval and QT dispersion were measured to determine the long-term effect of changes in ventricular systolic load on the ventricular repolarization. METHOD: Corrected QT interval and QT dispersion were measured in 26 patients before and 3-6 months after valvuloplasty for pulmonary stenosis. To determine the effect of ventricular load on ventricular repolarization, patients were divided in 2 groups; Group 1 was those patients with a greater than 30 mmHg and Group 2 was those patients with a less than 30 mmHg decrease in right ventricular systolic pressure. RESULTS: Corrected QT interval (412.6+/-14.5 msec vs 426.4+/-16.8 msec, p < 0.05) and QT dispersion (35.0+/-7.3 msec vs 45.7+/-14..1 msec, p < 0.05)were increased significantly only in Group 1 after vlavuloplasty. CONCLUSION: It suggested that mechanoelectrical interactions are operative for long duration in humans that changes in ventricular load after successful pulmonary valvuloplasty showed long-term effect on the ventricular repolarization.
Action Potentials ; Balloon Valvuloplasty* ; Blood Pressure ; Humans ; Pulmonary Valve Stenosis*

A woman presented severe mitral stenosis at 34 weeks' gestation. She did not respond to medical therapy, and underwent successful percutaneous mitral balloon valvuloplasty with monitored anesthetic care. The remainder of her pregnancy was uncomplicated, and she delivered a healthy infant at 38 weeks' gestation. We proved monitored anesthetic care is available method in percutaneous mitral balloon valvuloplasty for severe mitral stenosis during pregnancy.
Balloon Valvuloplasty* ; Female ; Humans ; Infant ; Mitral Valve Stenosis* ; Pregnancy*

Percutaneous balloon valvuloplasty is considered the standard of care for treatment of valvular pulmonic stenosis, a common congenital defect in dogs. Supravalvular pulmonic stenosis is a rare form of pulmonic stenosis in dogs and standard treatment has not been established. Although, there have been reports of successful treatment of supravalvular pulmonic stenosis with surgical and stenting techniques, there have been no reports of balloon dilation to treat dogs with this condition. Here, a case of supravalvular pulmonic stenosis diagnosed echocardiographically and angiographically in which a significant reduction in pressure gradient was achieved with balloon dilation alone is presented.
Angiography ; Angioplasty, Balloon, Coronary ; Animals ; Balloon Valvuloplasty ; Congenital Abnormalities ; Dogs* ; Pulmonary Valve Stenosis* ; Standard of Care ; Stents

BACKGROUND: Precutaneous mitral balloon valvuloplasty(PMV) is known to produce shortterm hemodynamic and symptomatic improvement in selected patients with restenosis after previous surgical commissurotomy. METHODS: To evaluated the long-term efficacy of PMV and identify the risk factors for restenosis after this procedure in patients with mitral restenosis after previous surgical commissurotomy, we obtained 30.4+/-13.0 months(range, 6-53) follow-up data in 19 patients with restenosis after previous surgical commissurotomy on whom PMV was successfully performed since April, 1988. RESULTS: There were 10 females and 9 males with mean age of 42.7+/-8.7(range, 28-59). 11 patients were in atrial fibrillation. Restenosis occurred in 8 patients(42%) during follow-up. Median value for restenosis by Kaplan-Meier survival analysis was 40 months. Restenosis by univariate analysis correlated with smaller valve area after PMV and short interval from previous surgical commissurotomy to restenosis. Mitral valve area after PMV and echoscore were found to be the determinant predictors of restenosis by Cox proportional hazard analysis. For mitral valve area after PMV, patients with post-PMV valve area less than 1.6cm2have relatively high risk for restenosis than those with post-PMV valve area more than 1.6cm2. CONCLUSION: Half of the patients who underwent PMV due to restenosis after previous surgical commissurotomy maintained optimal result up to 40 months. Poorer long-term outcome can be predicted in patients with unfavorable valve morphology or post-PMV valve area less than 1.6cm2.
Atrial Fibrillation ; Balloon Valvuloplasty* ; Echocardiography* ; Female ; Follow-Up Studies* ; Hemodynamics ; Humans ; Male ; Mitral Valve ; Risk Factors

Pulmonary atresia with intact ventricular septum has continued to have a high mortality and morbidity. The initial palliation is commonly a pulmonary valvotomy to achieve right ventricular decompression with or without a systemic to pulmonary shunt. There are only a few publications reporting practical experience with ductal stenting in neonates with pulmonary atresia. We report a case of pulmonary valvotomy followed of PDA stent insertion for the treatment of pulmonary atresia with intact ventricular septum.
Balloon Valvuloplasty* ; Decompression ; Humans ; Infant, Newborn ; Mortality ; Pulmonary Atresia* ; Stents* ; Ventricular Septum*

Percutaneous mitral ballon valvuloplasty(PMV) is an effective nonsurgical procedure for patients with mitral stenosis. PMV was performed in 13 patients(mean age, 41 years) with mitral stenosis. All patients underwent echophonocardiography(Echophono) before and after PMV. Two dilatation balloons were used in which the diameters approximately equaled the mitral valve annulus diameter as determined. After PMV, the mean mitral valve pressure gradient decreased(22.3+/-1.89mmHg to 5.2+/-2.6mmHg), the mean left atrial pressure decreased(21.3+/-5.1mmHg to 9.0+/-4.5mmHg) and the mitral valve area increased from 0.8+/-0.3cm2 to 1.7+/-0.6cm2. The Echophono data are correlated with clinical and hemodynamic changes produced by PMV. PMV resulted in echophono changes consistent with decresed severity of mitral stenosis ; shortening of Q-S1, from 88+/-14 to 73+/-11 mses(p<0.01) and (Q-S1)-(S2-OS), from 0.9+/-1.7 to -2.1+/-1.6(p<0.001) ; prolongation of S2-OS from 80+/-15 to 103+/-14 msec(p<0.001) and increase of EF slope from 14.7+/-5.4 to 26.7+/-8.1 mm/sec(p<0.001). Compared with pre-PMV, post-PMV Echophono showed significant decrease in the severity of mitral stenosis. Thus Echophono is a simple, low cost method helpful in evaluation and follow-up patients undergoing PMV.
Atrial Pressure ; Balloon Valvuloplasty ; Dilatation ; Follow-Up Studies ; Hemodynamics ; Humans ; Mitral Valve ; Mitral Valve Stenosis